SHENYANG, China, March 10 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced changes to its board of directors (the "Board"). Ms. Liping Xu, Executive Director and Vice President, will retire from the Board and her position as a company officer for health reasons, effective March 10, 2010. Ms. Xu was one of the founders of the company and has been a director of 3SBio and its predecessor company, Shenyang Sunshine, since 1993. Concurrently, effective March 10, 2010, Mr. Peiguo Cong will join the Board and serve as an independent, non-executive director.
Mr. Dan Lou, Chairman of the Board, said, "On behalf of the Board, I would
like to thank Ms. Xu for her significant contributions as a founder, director
and key executive of the company. We wish her well with her future endeavors."
He continued, "We are also pleased to welcome Mr. Cong to the Board as an
independent, non-executive dir
|SOURCE 3SBio Inc.|
Copyright©2010 PR Newswire.
All rights reserved